867 related articles for article (PubMed ID: 16110319)
1. The concept of synthetic lethality in the context of anticancer therapy.
Kaelin WG
Nat Rev Cancer; 2005 Sep; 5(9):689-98. PubMed ID: 16110319
[TBL] [Abstract][Full Text] [Related]
2. Chromosome instability and tumor lethality suppression in carcinogenesis.
Shen C; Zhou Y; Zhan J; Reske SN; Buck AK
J Cell Biochem; 2008 Dec; 105(6):1327-41. PubMed ID: 18821574
[TBL] [Abstract][Full Text] [Related]
3. Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?
Canaani D
Cancer Lett; 2014 Sep; 352(1):59-65. PubMed ID: 23962561
[TBL] [Abstract][Full Text] [Related]
4. Harnessing synthetic lethal interactions in anticancer drug discovery.
Chan DA; Giaccia AJ
Nat Rev Drug Discov; 2011 May; 10(5):351-64. PubMed ID: 21532565
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis and prediction of synthetic lethality using subcellular locations.
Yamada T; Kawashima S; Mamitsuka H; Goto S; Kanehisa M
Genome Inform; 2005; 16(1):150-8. PubMed ID: 16362917
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
[TBL] [Abstract][Full Text] [Related]
7. A lethal combination for cancer cells: synthetic lethality screenings for drug discovery.
Ferrari E; Lucca C; Foiani M
Eur J Cancer; 2010 Nov; 46(16):2889-95. PubMed ID: 20724143
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer cells by synthetic lethality: autophagy and VHL in cancer therapeutics.
Chan DA; Giaccia AJ
Cell Cycle; 2008 Oct; 7(19):2987-90. PubMed ID: 18818511
[TBL] [Abstract][Full Text] [Related]
9. Embracing synthetic lethality of novel anticancer therapies.
Kamal A; Shaik TB; Malik MS
Expert Opin Drug Discov; 2015 Oct; 10(10):1119-32. PubMed ID: 26211783
[TBL] [Abstract][Full Text] [Related]
10. [Synthetic lethality as a functional tool in basic research and in anticancer therapy].
Toma M; Skorski T; Sliwiński T
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1091-103. PubMed ID: 25228518
[TBL] [Abstract][Full Text] [Related]
11. Synthetic lethality and cancer.
O'Neil NJ; Bailey ML; Hieter P
Nat Rev Genet; 2017 Oct; 18(10):613-623. PubMed ID: 28649135
[TBL] [Abstract][Full Text] [Related]
12. Integrated genomic and pharmacological approaches to identify synthetic lethal genes as cancer therapeutic targets.
Mizuarai S; Irie H; Schmatz DM; Kotani H
Curr Mol Med; 2008 Dec; 8(8):774-83. PubMed ID: 19075675
[TBL] [Abstract][Full Text] [Related]
13. Synthetic lethal vulnerabilities of cancer.
Fece de la Cruz F; Gapp BV; Nijman SM
Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of drug inhibition of signalling molecules.
Sebolt-Leopold JS; English JM
Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
[TBL] [Abstract][Full Text] [Related]
15. Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling.
Farrand L; Byun S
Curr Pharm Des; 2017 Nov; 23(29):4311-4320. PubMed ID: 28699516
[TBL] [Abstract][Full Text] [Related]
16. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
17. Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agents.
Wang H; Han H; Mousses S; Von Hoff DD
Semin Oncol; 2006 Aug; 33(4):513-20. PubMed ID: 16890805
[TBL] [Abstract][Full Text] [Related]
18. Highlights in experimental therapeutics.
Burger AM
Cancer Lett; 2007 Jan; 245(1-2):11-21. PubMed ID: 16647200
[TBL] [Abstract][Full Text] [Related]
19. Cancer. Potential of the synthetic lethality principle.
Nijman SM; Friend SH
Science; 2013 Nov; 342(6160):809-11. PubMed ID: 24233712
[No Abstract] [Full Text] [Related]
20. Synthetic Lethal Interactions in Cancer Therapy.
Geng X; Wang X; Zhu D; Ying S
Curr Cancer Drug Targets; 2017; 17(4):304-310. PubMed ID: 27113746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
